Single Automated Analyzer to Bring Full Suite of Diagnostics to Wherever Patients Are

By HospiMedica International staff writers
Posted on 04 May 2023

Image: The single automated device can run hematology, clinical chemistry, and immunoassays subsystems in parallel (Photo courtesy of Freepik)

Timely and accurate diagnostics can enhance patient care by making it more informed, personalized, and proactive. Now, a novel platform that delivers swift results using minimal blood volumes incorporates technology that facilitates automation and adaptable form factors outside centralized labs, bridging the gap between diagnostics and treatment.

Vital Biosciences Inc. (Mississauga, ON, Canada) is developing a single automated device designed to provide a comprehensive range of diagnostics directly to patients. The company's technology strives to make healthcare significantly more personalized, proactive, and accessible. With only 600 uL of blood, the platform can measure 50+ of the most commonly requested biomarkers in primary care within 20 minutes, without compromising analytical performance. The instrument employs an automated microfluidic workflow to simultaneously run three subsystems: hematology, clinical chemistry, and immunoassays. The platform quantifies the complete panel of biomarkers using on-board optical readers and automated sample preparation and measurement procedures that require minimal user input. This makes the platform suitable for use in CLIA-waived settings.

Vital's initial menu caters to a broad range of potential use cases for the general population, including inflammation, cardiac markers, diabetes, liver disorders, lipid disorders, post-acute event monitoring, clinical trial monitoring, chronic disease management, and proactive lifestyle management. The company aims to create a comprehensive menu that covers 100% of the tests needed for at least 90% of patients, thereby eliminating the need to send tests to a centralized lab. Patients would no longer need to travel to a draw site or ship their samples to a centralized laboratory, nor wait for days to discuss their results with their healthcare provider. Patients who are likely to require bloodwork can provide their sample at check-in and receive results during their initial appointment. Bridging this care gap will make diagnostics more accessible and accelerate clinical decision-making.

Related Links:
Vital Biosciences Inc.

Visit expo >

Gold Member

Handheld Blood Glucose Analyzer

STAT-Site

Hand-held Hemoglobin Analyzer
DiaSpect Tm

Rapid Sepsis Test

SeptiCyte RAPID

Vessel Sealing Instrument

ERGOseal

Latest Point of Care News

Channels

Artificial Intelligence

view channel

$Image: Mass General Brigham researchers developed two AI tools from one foundation model (called FAHR-Face) that can estimate biological age and predict cancer survival outcomes from a single face photo. The image on the left depicts the features most important to FAHR-FaceSurvival\'s predictions of cancer survival outcomes, while the image on the right shows the features most important to FAHR-FaceAge\'s estimates of biological age. Areas shown in yellow had the greatest influence on each model\'s predictions. (Photo courtesy of Mass General Brigham/Lancet Digital Health)$

$Image: Purdue University physicist David Nolte is developing a biodynamic imaging system that could improve the care of cancer patients undergoing chemotherapy. Nolte\'s system can rapidly evaluate the outcome of different chemotherapy drugs on patient biopsies (obtained during diagnosis), which could ensure patients get the chemotherapy treatment that would be most effective on their specific tumor. Right now, the system is being used at the Indiana University School of Medicine to evaluate the impact of experimental chemotherapy drugs on tumor cells derived from more than 30 osteosarcoma patients. It has also been used in clinical and preclinical trials. (IMage Credit: Purdue University/Kelsey Lefever)$

Optical Imaging System Helps Predict Chemotherapy Response in Cancer

Selecting chemotherapy can be difficult because tumors from different patients may respond differently to the same drug. Testing treatment effects directly on living tumor tissue could help clinicians... Read more

Critical Care

view channel

Smart Medical Adhesive Patch Uses Heat to Enable Gentle Removal

Medical adhesive-related skin injury (MARSI) is a persistent concern for neonates, older adults, critically ill patients, and others requiring repeated monitoring. Strong adhesives keep sensors securely... Read more

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Proposed Risk Score Prioritizes Sickest Patients for Heart Transplant

Donor hearts remain extremely scarce in the U.S. transplant system, with one in five candidates dying or being removed from the waiting list before receiving an organ. Current allocation rules may also... Read more

Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that damages nerve cells controlling voluntary muscles. As the disease advances, patients can lose the ability to walk, speak,... Read more

Surgical Techniques

view channel

Combined Wound Healing Approach Pairs Synthetic Scaffold With Negative Pressure Therapy

Managing complex wounds requires both structural support for tissue repair and a controlled environment that protects the healing process. Frequent dressing changes can disrupt the wound bed and add complexity... Read more

Shape-Changing Hydrogels Show Promise for Tissue Engineering and Wound Healing

Human tissues often have complex three-dimensional shapes that are closely tied to their function, but recreating these curvatures remains challenging in tissue engineering and wound repair.... Read more

$Image: The new technology uses augmented reality to overlay a 3D visualization of the tumor and other anatomical structures on the surgeon\'s camera view. Here, Niclas Kvarnström, transplant surgeon and head of the Transplant Centre, and Fatuma Shieriye, specialist physician, perform the first operation using the new technology. (Image Credit: Jenny Cedås)$